30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jordan Julie

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -20% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Jordan Julie's trades of Neurogene Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26
US Neurogene Inc (NGNE)
S Sale
58,366 -43.8%
163.95
US$556,660 		58,366 -43.8% 163.95 US$556,660
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
S Sale
61,236 +18.3%
158.40
US$153,722 		61,236 +18.3% 158.40 US$153,722
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
84,788 +5.1%
225.62
US$3,211,944 		84,788 +5.1% 225.62 US$3,211,944
2023-08-07 2023-08-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
436 -10.1%
1.39
US$606 		436 -10.1% 1.39 US$606
2023-08-04 2023-08-02
US Q32 Bio Inc (QTTB)
PlS Planned sale
99 -3.5%
1.31
US$130 		99 -3.5% 1.31 US$130